About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Cuba Registers New Antibody

by Medindia Content Team on June 26, 2006 at 4:08 PM
Font : A-A+

Cuba Registers New Antibody

Cuba's Center for Genetic Engineering and Biotechnology (CIGB) has registered the first recombinant monoclonal antibody to be used in the production of an anti-hepatitis B vaccine.

CIGB Deputy Director General Carlos Borroto described it as a true world scientific breakthrough, and it was obtained after having completed all necessary stages of the technological process required for it.

Advertisement

At a press conference in Havana, Borroto said it was the result of research work similar to what is being developed by research teams from dozens of highly developed nations.

Baptized as CB-Hep.1, the recombinant monoclonal antibody made of plants is of great relevance to increase the production of the anti-hepatitis B vaccine at a lower cost.

From the research point of view, this breakthrough leaves a door opened to obtain other effective antibodies to fight illnesses, including cancer.

(Source:PTI News)
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
January is the Thyroid Awareness Month in 2022
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)